ALAB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Astera Labs (ALAB) shows strong long-term growth potential driven by AI infrastructure demand and financial growth. However, the stock appears overbought based on RSI, and recent insider selling may indicate caution. For a beginner investor with a long-term horizon, it is better to wait for a more favorable entry point.
The MACD is positive and contracting, indicating a bullish trend, but RSI at 87.293 suggests the stock is overbought. Moving averages are converging, and the stock is trading near resistance levels (R1: 168.618).
Strong Q4 financials with 91.77% YoY revenue growth and 82.02% YoY net income growth. Positive analyst sentiment citing AI infrastructure growth. Hedge funds are significantly increasing their positions.
Recent insider selling by Jitendra Mohan. RSI indicates overbought conditions. Citi and JPMorgan lowered price targets citing margin and expense concerns.
In Q4 2025, revenue increased by 91.77% YoY to $270.58M, net income grew 82.02% YoY to $44.98M, and EPS rose by 66.67% YoY to $0.25. Gross margin improved slightly to 75.57%.
Analysts maintain a Buy rating with price targets ranging from $200 to $250, citing AI-driven growth opportunities. However, some firms have reduced targets due to margin and expense concerns.
